Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9604304rdf:typepubmed:Citationlld:pubmed
pubmed-article:9604304lifeskim:mentionsumls-concept:C0026447lld:lifeskim
pubmed-article:9604304lifeskim:mentionsumls-concept:C1280551lld:lifeskim
pubmed-article:9604304lifeskim:mentionsumls-concept:C0025914lld:lifeskim
pubmed-article:9604304lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:9604304lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:9604304lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:9604304lifeskim:mentionsumls-concept:C0022702lld:lifeskim
pubmed-article:9604304lifeskim:mentionsumls-concept:C0743223lld:lifeskim
pubmed-article:9604304lifeskim:mentionsumls-concept:C0248500lld:lifeskim
pubmed-article:9604304pubmed:issue4lld:pubmed
pubmed-article:9604304pubmed:dateCreated1998-7-10lld:pubmed
pubmed-article:9604304pubmed:abstractText1. Radiometric and UV analyses indicated > 95% unchanged cobalt mesoporphyrin (CoMP) in plasma after i.v. or i.m. administration. Blood clearance of CoMP is < 2% of hepatic blood flow in mouse and rat, and < 0.5% of hepatic blood flow in monkey and dog. CoMP elimination t1/2 ranged from 3.1 to 9.9 days in animals after i.v. administration. 2. CoMP is highly (> 99.5%) bound to plasma proteins, but has low affinity for blood cells (Kp < 0.15). The volume of CoMP distribution (Vss < 0.91/kg) is reflective of a distribution to total body water following i.v. administration to mouse, rat, monkey and dog. 3. [14C]CoMP reached highest levels in rat tissue between 1 and 4 days following i.m. injection. Liver, kidney cortex, lymph node, adrenal and spleen demonstrated greatest uptake of radiolabel. Concentration in tissues was readily detectable at 60 days post-dose. 4. CoMP was slowly absorbed after i.m. administration showing dose-dependent pharmacokinetics. The major route of radiolabel elimination was faecal excretion (54% of dose) in rat after an i.m. dose of [14C]CoMP. Approximately 1% of the 14C dose was recovered in the urine over 7 days post-dose. 5. As a polar metalloporphyrin, CoMP has low clearance, restricted tissue distribution and long elimination t1/2 in the laboratory animals.lld:pubmed
pubmed-article:9604304pubmed:languageenglld:pubmed
pubmed-article:9604304pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9604304pubmed:citationSubsetIMlld:pubmed
pubmed-article:9604304pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9604304pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9604304pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9604304pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9604304pubmed:statusMEDLINElld:pubmed
pubmed-article:9604304pubmed:monthAprlld:pubmed
pubmed-article:9604304pubmed:issn0049-8254lld:pubmed
pubmed-article:9604304pubmed:authorpubmed-author:BlackAAlld:pubmed
pubmed-article:9604304pubmed:authorpubmed-author:DehartPPlld:pubmed
pubmed-article:9604304pubmed:authorpubmed-author:McNallyWWlld:pubmed
pubmed-article:9604304pubmed:authorpubmed-author:RooseH HHHlld:pubmed
pubmed-article:9604304pubmed:authorpubmed-author:FineI TITlld:pubmed
pubmed-article:9604304pubmed:authorpubmed-author:LovdahlMMlld:pubmed
pubmed-article:9604304pubmed:authorpubmed-author:StrenkoskiCClld:pubmed
pubmed-article:9604304pubmed:issnTypePrintlld:pubmed
pubmed-article:9604304pubmed:volume28lld:pubmed
pubmed-article:9604304pubmed:ownerNLMlld:pubmed
pubmed-article:9604304pubmed:authorsCompleteYlld:pubmed
pubmed-article:9604304pubmed:pagination413-26lld:pubmed
pubmed-article:9604304pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:9604304pubmed:meshHeadingpubmed-meshheading:9604304-...lld:pubmed
pubmed-article:9604304pubmed:meshHeadingpubmed-meshheading:9604304-...lld:pubmed
pubmed-article:9604304pubmed:meshHeadingpubmed-meshheading:9604304-...lld:pubmed
pubmed-article:9604304pubmed:meshHeadingpubmed-meshheading:9604304-...lld:pubmed
pubmed-article:9604304pubmed:meshHeadingpubmed-meshheading:9604304-...lld:pubmed
pubmed-article:9604304pubmed:meshHeadingpubmed-meshheading:9604304-...lld:pubmed
pubmed-article:9604304pubmed:meshHeadingpubmed-meshheading:9604304-...lld:pubmed
pubmed-article:9604304pubmed:meshHeadingpubmed-meshheading:9604304-...lld:pubmed
pubmed-article:9604304pubmed:meshHeadingpubmed-meshheading:9604304-...lld:pubmed
pubmed-article:9604304pubmed:meshHeadingpubmed-meshheading:9604304-...lld:pubmed
pubmed-article:9604304pubmed:meshHeadingpubmed-meshheading:9604304-...lld:pubmed
pubmed-article:9604304pubmed:meshHeadingpubmed-meshheading:9604304-...lld:pubmed
pubmed-article:9604304pubmed:meshHeadingpubmed-meshheading:9604304-...lld:pubmed
pubmed-article:9604304pubmed:meshHeadingpubmed-meshheading:9604304-...lld:pubmed
pubmed-article:9604304pubmed:meshHeadingpubmed-meshheading:9604304-...lld:pubmed
pubmed-article:9604304pubmed:year1998lld:pubmed
pubmed-article:9604304pubmed:articleTitleDisposition kinetics of cobalt mesoporphyrin in mouse, rat, monkey and dog.lld:pubmed
pubmed-article:9604304pubmed:affiliationParke-Davis Pharmaceutical Research, Division of Warner-Lambert Co, Ann Arbor, MI 48105, USA.lld:pubmed
pubmed-article:9604304pubmed:publicationTypeJournal Articlelld:pubmed